3which is the systemic drug of choice.1It controls psoriatic lesions by decreasing RNA and DNA synthesis in the T lymphocytes and keratinocytes of affected skin and also acts downstream by decreasing cytokine and messenger protein production. Methotrexate has a favourable side...